FDA Clearance for hESC Clinical Trial to Treat AMD, Advanced Cell Technology (ACTC.OB)
January 3rd, 2011
No comments
The US FDA has cleared the Investigational New Drug (IND) application Read more…
Categories: IND Application Cleared, NASDAQ: ACTC.OB, Stem Cell Technology
